Terminated NCT00535262
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
Remote / online Why is this study shown? This study includes Depression among several conditions.
Bipolarity, Depression Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States
Sponsor New York State Psychiatric Institute
Condition Bipolarity, Depression Suspended NCT02719392
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
In United States Why is this study shown? This study includes Depression among several conditions.
Bipolarity, Depression Behavioral From 18 Years to 65 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition Bipolarity, Depression Completed NCT00363337
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Depression among several conditions.
Bipolarity, Depression Drug Over 18 Years
Countries United States
Sponsor Lindner Center of HOPE
Condition Bipolarity, Depression Completed NCT02192931
This study is completed in the United States. It focuses on Addiction.
In United States Why is this study shown? This study includes Depression among several conditions.
Addiction, Depression Drug From 18 Years to 55 Years
Countries United States
Sponsor Perry Renshaw
Condition Addiction, Depression Completed NCT00260195
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Depression among several conditions.
PTSD, Depression Behavioral From 10 Years to 14 Years
Countries United States
Sponsor RAND
Condition PTSD, Depression Completed NCT00282464
This study is completed in the United States. It is testing geodon for depression.
In United States Why is this study shown? This study includes Depression among several conditions.
Bipolarity, Depression Drug Over 18 Years
Countries United States
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Bipolarity, Depression Completed NCT00141271
This study is completed in the United States. It is testing geodon for depression.
In United States Why is this study shown? This study includes Depression among several conditions.
Bipolarity, Depression Drug Over 18 Years
Countries United States
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Bipolarity, Depression Completed NCT00844857
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Depression among several conditions.
Bipolarity, Depression Drug From 10 Years to 17 Years
Countries United States, Russia
Sponsor Eli Lilly and Company
Condition Bipolarity, Depression Completed NCT05328297
This study is completed in the United States, in Canada, in Poland, .... It is testing JNJ-55308942 for depression in bipolarity.
In United States Why is this study shown? This study includes Depression among several conditions.
Bipolarity, Depression Drug From 18 Years to 64 Years
Countries United States, Canada, Poland, ...
Sponsor Janssen Pharmaceutica N.V., Belgium
Condition Bipolarity, Depression Terminated NCT00939887
This study was terminated in the United States. It focuses on Bipolarity.
In United States Why is this study shown? This study includes Depression among several conditions.
Bipolarity, Depression Drug From 18 Years to 55 Years
Countries United States
Sponsor Pfizer
Condition Bipolarity, Depression Completed NCT00812058
This study is completed in the United States. It is testing Safety, Tolerability and Efficacy of RG2417 for depression.
In United States Why is this study shown? This study includes Depression among several conditions.
Bipolarity, Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor Repligen Corporation
Condition Bipolarity, Depression Completed NCT05931432
This study is completed in the United States. It focuses on Anxiety.
In United States Why is this study shown? This study includes Depression among several conditions.
Anxiety, Depression Behavioral Over 18 Years
Countries United States
Sponsor University of Pennsylvania
Condition Anxiety, Depression 
